Literature DB >> 17405005

[Guattegaumerine, New Bisbenzylisoquinoline Alkaloid from Guatteria gaumeri.].

H Dehaussy1, M Tits, L Angenot.   

Abstract

The aqueous-alcoholic extract of the bark of GUATTERIA GAUMERI (Mexican Annonaceae) is used for the treatment of cholelithiasis and hypercholesterolemia. Therefore it seems very interesting to perform a phytochemical study of this drug in order to know its composition and to determine, if possible, all the active principles. We describe now the isolation of the main alkaloid named guattegaumerine. This new bisbenzylisoquinoline alkaloid has been assigned structure 1, on the basis of spectroscopic, chemical and chromatographic evidence.

Entities:  

Year:  1983        PMID: 17405005     DOI: 10.1055/s-2007-969803

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  Formal synthesis of the bisbenzylisoquinoline alkaloid berbamunine by asymmetric substitution of chiral organolithium compounds.

Authors:  Robert E Gawley; Gregory A Smith
Journal:  ARKIVOC       Date:  2011-01-30       Impact factor: 1.140

2.  Effects of Verapamil and Two Bisbenzylisoquinolines, Curine and Guattegaumerine Extracted from Isolona hexaloba, on the Inhibition of ABC Transporters from Pseudomonas aeruginosa.

Authors:  Christian Hulen; Pierre-Jean Racine; Marc Feuilloley; Abdelhakim Elomri; Nour-Eddine Lomri
Journal:  Antibiotics (Basel)       Date:  2022-05-21

3.  Effects of Two Natural Bisbenzylisoquinolines, Curine and Guattegaumerine, Extracted from Isolona hexaloba on Rhodamine Efflux by Abcb1b from Rat Glycocholic-Acid-Resistant Hepatocarcinoma Cells.

Authors:  Jacques-Aurélien Sergent; Hilarion Mathouet; Christian Hulen; Pedro Lameiras; Marc Feuilloley; Abdelhakim Elomri; Nour-Eddine Lomri
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.927

4.  Complete biosynthesis of the bisbenzylisoquinoline alkaloids guattegaumerine and berbamunine in yeast.

Authors:  James T Payne; Timothy R Valentic; Christina D Smolke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.